VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Charles B NemeroffStephen K Brannan

Abstract

Currently available therapeutic interventions for treatment-resistant depression, including switch, combination, and augmentation strategies, are less than ideal. Observations of mood elevation during vagus nerve stimulation (VNS) therapy for pharmacoresistant epilepsy suggested a role for VNS therapy in refractory major depression and prompted clinical investigation of this neurostimulation modality. The VNS Therapy System has been available for treatment of pharmacoresistant epilepsy since 1997 and was approved by the US Food and Drug Administration for treatment-resistant depression in July, 2005. The physiology of the vagus nerve, mechanics of the VNS Therapy System, and efficacy and safety in pharmacoresistant epilepsy are reviewed. Promising results of VNS therapy for treatment-resistant depression have been forthcoming from both acute and long-term studies, evidenced in part by progressive improvements in depression rating scale scores during the 1st year of treatment with maintenance of response thereafter. VNS therapy is well tolerated in patients with either pharmacoresistant epilepsy or treatment-resistant depression. As in epilepsy, the mechanisms of VNS therapy of treatment-resistant depression are incompletely und...Continue Reading

References

Oct 5, 1979·Brain Research·J Siegel, G J Murphy
Apr 12, 1974·Brain Research·D A Kovacs, J G Zoll
Aug 1, 1993·Journal of Pain and Symptom Management·K M Foley, R K Portenoy
Aug 1, 1996·Journal of Pain and Symptom Management·R K Portenoy
Jun 11, 1999·Current Opinion in Biotechnology·G M Binder
Feb 25, 2000·Biological Psychiatry·J F Rosenbaum, G Heninger
Feb 25, 2000·Biological Psychiatry·M S GeorgeJ C Ballenger
Jan 9, 2001·The Psychiatric Clinics of North America·M S GeorgeA J Rush
Feb 7, 2001·The American Journal of Psychiatry·M S NoblerJ J Mann
Feb 15, 2001·JAMA : the Journal of the American Medical Association·C M MichaudB R Bloom
Feb 24, 2001·Autonomic Neuroscience : Basic & Clinical·H R Berthoud, W L Neuhuber
Feb 24, 2001·British Journal of Neurosurgery·G S Malhi, J R Bartlett
Mar 20, 2001·JAMA : the Journal of the American Medical Association·H A SackeimJ Prudic
Aug 31, 2001·The Journal of ECT·S H LisanbyH A Sackeim
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·H A SackeimR R Goodman
Apr 18, 2002·Biological Psychiatry·Lauren B MarangellSarah H Lisanby
Jun 13, 2002·Mayo Clinic Proceedings·Keith G RasmussenTeresa A Rummans
Sep 25, 2002·Neurology·Thomas R Henry
Dec 7, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Wayne C DrevetsMarcus E Raichle
Mar 1, 2003·Epilepsy & Behavior : E&B·Cynthia L. HardenDouglas R. Labar
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Aug 2, 2003·Biological Psychiatry·Robert M Carney, Kenneth E Freedland
Aug 9, 2003·Der Nervenarzt·C KellinghausH O Lüders
Sep 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Keith Matthews, Muftah S Eljamel
Oct 18, 2003·Journal of Psychiatric Research·Jeong-Ho ChaeMark S George
Jan 28, 2004·Biological Psychiatry·Joan PrudicHarold A Sackeim

❮ Previous
Next ❯

Citations

Jan 10, 2012·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Beata Majkowska-ZwolińskaKrzysztof Drabik
Jan 27, 2010·Acta neurochirurgica·Pablo AndradeVeerle Visser-Vandewalle
Jun 6, 2013·Journal of Neural Transmission·Helge H MüllerWolfgang Sperling
May 14, 2008·Current Psychiatry Reports·Zheya Jenny YuElizabeth B Weller
Jan 8, 2008·Psychological Medicine·T E SchlaepferM Hasdemir
Sep 18, 2009·Nature·Meredith Wadman
Oct 25, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J Thomas CunninghamAlan Frazer
Aug 31, 2011·Proceedings of the National Academy of Sciences of the United States of America·Javier A BravoJohn F Cryan
Aug 21, 2010·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Chris C StreeterJ Eric Jensen
May 28, 2010·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·J P Beekwilder, T Beems
Feb 19, 2008·Current Opinion in Psychiatry·Paul B Fitzgerald, Zafiris J Daskalakis
Jan 26, 2011·Lipids in Health and Disease·Undurti N Das
Mar 15, 2008·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Ryan J Van Lieshout, Glenda Macqueen
Apr 7, 2007·Medicine and Science in Sports and Exercise·Ali A WeinsteinWillem J Kop
Dec 4, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Peter J Schwartz
Feb 18, 2010·Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies·Shaoyong SuViola Vaccarino
Nov 16, 2012·Medical Devices : Evidence and Research·Khalid Saad Al-Harbi, Naseem Akhtar Qureshi
Jan 22, 2010·CNS Drugs·Richard C SheltonSara A Corya
Jul 2, 2008·Neurosurgical Focus·Aviva Abosch, G Rees Cosgrove
Nov 29, 2012·F1000 Medicine Reports·Paul E Holtzheimer, Helen S Mayberg
Jan 1, 2008·Mens Sana Monographs·Elise Langdon-Neuner
Apr 29, 2011·World Journal of Cardiology·Undurti N Das
May 23, 2009·Journal of Psychiatric Practice·Sheldon H Preskorn
Dec 18, 2010·Heart Failure Reviews·Gaetano M De Ferrari, Peter J Schwartz
Dec 26, 2006·Expert Review of Neurotherapeutics·Mark S GeorgeE Baron Short
Aug 7, 2009·Journal of Affective Disorders·Sidney H KennedyUNKNOWN Canadian Network for Mood and Anxiety Treatments (CANMAT)
Apr 6, 2016·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Simone RossiMonica Ulivelli
Aug 1, 2015·Journal of Cognitive Neuroscience·Roberta SellaroLorenza S Colzato
Jul 27, 2015·European Archives of Psychiatry and Clinical Neuroscience·Alkomiet HasanThomas Wobrock
Feb 23, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Ru-Peng LiuBing Zhu
Dec 5, 2014·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Lucio OldaniAllan H Young
Sep 6, 2014·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Aparna ShahAlan Frazer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.